High Vista Strategies LLC Global Blood Therapeutics, Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $516,824 - $866,550	23,176 Added 45.37%	74,261 $2.37 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $1.31 Million - $1.82 Million	51,085 New	51,085 $1.77 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $677,127 - $884,230	-17,389 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $370,476 - $627,496	9,840 Added 130.35%	17,389 $753,000
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $67,954 - $95,943	1,288 Added 20.57%	7,549 $416,000
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $305,098 - $512,275	6,261 New	6,261 $395,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.